First Documentation of In Vivo and In Vitro Ivermectin Resistance in Sarcoptes scabiei

Bart Currie, P Harumal, M McKinnon, Shelley Walton

    Research output: Contribution to journalArticle

    Abstract

    Ivermectin is increasingly being used to treat scabies, especially crusted (Norwegian) scabies. However, treatment failures, recrudescence, and reinfection can occur, even after multiple doses. Ivermectin resistance has been documented for some intestinal helminths in animals with intensive ivermectin exposure. Ivermectin resistance has also been induced in arthropods in laboratory experiments but, to date, has not been documented among arthropods in nature. We report clinical and in vitro evidence of ivermectin resistance in 2 patients with multiple recurrences of crusted scabies who had previously received 30 and 58 doses of ivermectin over 4 and 4.5 years, respectively. As predicted, ivermectin resistance in scabies mites can develop after intensive ivermectin use.
    Original languageEnglish
    Pages (from-to)-
    JournalClinical Infectious Diseases
    Volume39
    Issue number1
    Publication statusPublished - 2004

    Fingerprint Dive into the research topics of 'First Documentation of In Vivo and In Vitro Ivermectin Resistance in Sarcoptes scabiei'. Together they form a unique fingerprint.

    Cite this